Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Enterprise Value

Aerie Pharmaceuticals Enterprise Value Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Enterprise Value from 2013 to 2020.
  • Aerie Pharmaceuticals Enterprise Value for the quarter ending September 09, 2020 was $511m a -2.00% decrease of -10m year over year
  • Aerie Pharmaceuticals Enterprise Value for the last 12 months ending September 09, 2020 was $511m a -2.00% decrease of -10m year over year
  • Aerie Pharmaceuticals Annual Enterprise Value for 2020 was $511m a 0.00% decrease of 0m from 2019
  • Aerie Pharmaceuticals Annual Enterprise Value for 2020 was $511m a -5.73% decrease of -29m from 2019
  • Aerie Pharmaceuticals Annual Enterprise Value for 2020 was $541m a 3.53% increase of 19m from 2019
Other Valuation Metrics:
  • Aerie Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $2,142m a 11.86% increase of 254m year over year
  • Aerie Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 14.78 a -42.15% decrease of -6.23 year over year
View Chart On Koyfin

Quarterly AERI Enterprise Value Data

09/2020$511m
09/2020$511m
09/2020$541m
09/2020$521m
09/2020$517m
09/2020$510m
09/2020$490m
09/2020$460m
09/2020$477m
09/2020$514m

Annual AERI Enterprise Value Data

2020$511m
2020$511m
2020$541m
2020$521m
2020$517m
2020$510m
2020$490m
2020$460m
2020$477m
2020$514m